Early (6 months) results of a pilot prospective study to investigate the efficacy and safety of sirolimus coated balloon angioplasty for dysfunctional arterio-venous fistulas: MAgicTouch Intervention Leap for Dialysis Access (MATILDA) Trial.

Tjun Y TangShereen Xue Yun SoonCharyl J Q YapSze Ling ChanRu Yu TanSuh Chien PangShaun Q W LeeHao Yun YapEdward T C ChokeChieh Suai TanTze Tec Chong

Published in: PloS one (2020)

SCB angioplasty for dysfunctional AVF circuits is a safe and efficacious modality in Asian haemodialysis patients at six months comparable if not better than the paclitaxel data reported to date in the literature.

Keyphrases

study protocol
end stage renal disease
randomized controlled trial
chronic kidney disease
peritoneal dialysis
systematic review
clinical trial
phase iii
electronic health record
big data
phase ii
artificial intelligence